Insights

Early-Stage Advantage Target PathoGene as a seed-stage, innovation-driven MedTech startup expanding its capabilities in sample-to-answer diagnostics; position our supportive solutions to accelerate R&D, regulatory readiness, and market entry.

Custom Lab Automation Sell robotics-enabled workflow optimization and cloud-based data reporting tools to enhance their 6-hour pathogen detection panel, enabling scalable operations and faster time-to-result for customers.

Bioinformatics Platform Offer sequencing, data analytics, and real-time reporting infrastructure to strengthen their molecular diagnosis and antimicrobial resistance profiling, increasing clinical impact and surveillance integration.

Strategic Financing Fit Leverage their seed funding and modest revenue to propose phased collaborations, milestones-based partnerships, and grant-ready projects that align with their growth trajectory and risk tolerance.

Public Health Alignment Position the solution as a global standard-of-care advancement for infectious disease diagnostics, aligning with healthcare providers, labs, and surveillance systems to unlock partner opportunities with large networks and distributors.

Similar companies to PathoGene, Inc.

PathoGene, Inc. Tech Stack

PathoGene, Inc. uses 8 technology products and services including AT Internet XiTi, Hotjar, Amazon Web Services, and more. Explore PathoGene, Inc.'s tech stack below.

PathoGene, Inc.'s Email Address Formats

PathoGene, Inc. uses at least 2 email formats:
PathoGene, Inc. Email FormatsExamplePercentage
FirstLast@pathogene.comJohnDoe@pathogene.com
75%
FLast@pathogene.comJDoe@pathogene.com
25%

Frequently Asked Questions

What is PathoGene, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
PathoGene, Inc.'s official website is pathogene.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does PathoGene, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, PathoGene, Inc.'s annual revenue is estimated to be $1M - $10M.

What is PathoGene, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
PathoGene, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does PathoGene, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, PathoGene, Inc. has approximately 2 employees across 2 continents, including North America and Oceania. Key team members include Chief Executive Officer: J. M., Chief Data Officer: C. P. and Cofounder & Chief Visionary Officer: J. M. Explore PathoGene, Inc.'s employee directory with LeadIQ.

What industry does PathoGene, Inc. belong to?

Minus sign iconPlus sign icon
PathoGene, Inc. operates in the Medical Equipment Manufacturing industry.

What technology does PathoGene, Inc. use?

Minus sign iconPlus sign icon
PathoGene, Inc.'s tech stack includes AT Internet XiTi, Hotjar, Amazon Web Services, jQuery CDN, Google Workspace, Google Fonts API, Impact Radius and Webflow.

What is PathoGene, Inc.'s email format?

Minus sign iconPlus sign icon
PathoGene, Inc.'s email format typically follows the pattern of FirstLast@pathogene.com. Find more PathoGene, Inc. email formats with LeadIQ.

How much funding has PathoGene, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, PathoGene, Inc. has raised $500K in funding. The last funding round occurred on Jul 14, 2021 for $500K.

When was PathoGene, Inc. founded?

Minus sign iconPlus sign icon
PathoGene, Inc. was founded in 2020.
PathoGene, Inc. logo

PathoGene, Inc.

Medical Equipment ManufacturingCalifornia, United States2-10 Employees

PathoGene, Inc. is a seed-stage medical device company focused on developing a sample-to-answer in vitro diagnostic platform intended to detect and identify all known microscopic human pathogens and their antimicrobial resistance profiles within a single six-hour test. Headquartered in Los Angeles with R&D operations in Monrovia, California, the privately held startup aims to provide rapid molecular diagnostics that can inform treatment decisions and support disease surveillance in real time. The company serves the medical field, targeting doctors, medical staff, and care facilities that require timely, accurate pathogen identification and resistance information to optimize patient care. Positioned within the medical equipment manufacturing industry, PathoGene emphasizes an integrated, automated workflow to deliver diagnostic results that could become a standard of care for infectious disease diagnosis, operating from its California base at the intersection of robotics, sequencing, and data integration. A recent development noted is the company’s ongoing work on its sample-to-answer technology, reflecting its focus on advancing diagnostic capabilities in the infectious disease space.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2020
Employees
2-10

Section iconFunding & Financials

  • $500K

    PathoGene, Inc. has raised a total of $500K of funding over 1 rounds. Their latest funding round was raised on Jul 14, 2021 in the amount of $500K as a Seed.

  • $1M - $10M

    PathoGene, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.